Glucuronyl transferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum positioning function as well as preparation method and application of glucuronyl transferase UGT1A10 specific fluorescent probe substrate

By designing a specific fluorescent probe substrate N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide, the selectivity and visualization challenges of UGT1A10 enzyme detection in existing technologies have been solved, achieving highly sensitive enzyme activity detection suitable for the determination of UGT1A10 enzyme activity in mammalian cells and tissues.

CN121318844APending Publication Date: 2026-01-13CHENGDE MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511446759.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-10-11
Publication Date
2026-01-13

AI Technical Summary

Technical Problem

Existing technologies cannot achieve high selectivity and real-time visualization of UGT1A10 enzymes, and traditional probe substrates cannot be effectively used in vivo, limiting the safe use of drugs such as irinotecan.

Method used

A specific fluorescent probe substrate, N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide, was designed to generate a glucuronidation product with good fluorescence properties by reacting with the UGT1A10 enzyme. The amount of product generated was detected by a fluorescence spectrophotometer to quantify enzyme activity.

Benefits of technology

This probe substrate has high specificity and sensitivity, enabling real-time quantitative detection of the UGT1A10 enzyme in vivo, reducing detection costs, and causing minimal interference to biological systems. It is suitable for measuring the activity of the UGT1A10 enzyme in mammalian cells and tissues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121318844A_ABST
    Figure CN121318844A_ABST
Patent Text Reader

Abstract

The invention discloses a UGT1A10 fluorescent probe substrate with endoplasmic reticulum targeting characteristic and preparation and application thereof, the substrate is not applied to diagnosis and treatment of diseases, and the substrate is characterized in that the structural formula of the substrate is as shown in formula (I). The preparation method comprises the following steps: taking N, N-dimethyl-ethyl-4-bromo-1, 8-naphthalimide and p-hydroxyphenylboronic acid as raw materials, and carrying out palladium-catalyzed Suzuki coupling reaction to obtain the compound. The probe substrate can be used for quantitatively determining the activity of UGT1A10 in various biological systems such as recombinase, cells, tissues and the like, and can be used for rapidly screening inducers and inhibitors of UGT1A10. The probe provided by the invention has high specificity, high sensitivity, low cytotoxicity and excellent endoplasmic reticulum co-localization capability, and provides an effective tool for functional research of UGT1A10 and development of related drugs.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The application belongs to the technical field of fluorescent probe materials, and particularly relates to a specific fluorescent probe substrate for glucose uronosyltransferase UGT1A10 with endoplasmic reticulum positioning function and a preparation method and application thereof. BACKGROUND

[0002] The uridine diphosphate-glucuronosyltransferase (UGT) superfamily is an important phase II metabolic enzyme in the body, which catalyzes the combination of compounds and the cofactor uridine diphosphate glucuronide (UDPGA), thereby increasing the hydrophilicity of the substrate, so that it can be more effectively discharged from the body in urine or bile, which is an important detoxification process of the body. The detoxification of various exogenous substances, such as etoposide and irinotecan, and endogenous substances, such as bilirubin and estradiol, is achieved through the glucuronidation pathway.

[0003] Human UGTs can be divided into four families: UGT1, UGT2, UGT3 and UGT8. Among them, UGT1 and UGT2 families are the most important two subfamilies, which are mainly responsible for the conjugation reaction of drugs. So far, 25 kinds of UGT enzymes have been identified in humans, including 16 subtypes of UGT1A subfamily and 7 subtypes of UGT2B subfamily, most of which are mainly expressed in the liver, but UGT1A10 is mainly distributed in the stomach and intestine, and participates in the metabolism and clearance of various endogenous and exogenous substances such as flavones, mycophenolic acids and first-line anticancer drug irinotecan through glucuronide conjugation reaction, which has important physiological significance. In addition, due to the high similarity of each subtype in UGT in the amino acid sequence, there is a lack of specific probes for each subtype of UGT. In UGT1A, UGT1A10 is closely related to human health, and UGT1A10 is also an important metabolic enzyme of irinotecan (SN-38, an active metabolite of a widely used anticancer drug), and the loss of activity of UGT1A10 is proved to be related to the toxicity of irinotecan. Therefore, it is of great significance for the safe use of drugs (such as irinotecan) metabolized by UGT1A10 in the clinic to establish a simple, rapid and non-invasive in situ method to dynamically detect the activity of UGT1A10.

[0004] In recent years, small molecule fluorescent probes have attracted great attention in the detection of metabolic enzyme activity. Fluorescent probes have the advantages of high selectivity, high sensitivity, simple operation, visual detection, etc. At present, the most likely probe substrate for UGT1A10 reported is dopamine and estrone, but since they both belong to endogenous substances, they cannot be used as in vivo probes. At the same time, it is also difficult to realize the visualization and real-time monitoring of UGT1A10 in vivo, which also limits it to become an in vivo UGT1A10 probe substrate.

[0005] Therefore, developing a more secure, high selectivity and better positioning ability of the probe substrate is a technical problem to be solved. SUMMARY

[0006] The present application provides a new fluorescent probe substrate to solve the problems in the prior art, the specific fluorescent probe has no fluorescence, and its glucuronidation product has good fluorescence properties, the product has high fluorescence quantum yield, and the generated fluorescence intensity is strong and easy to detect. Based on this fluorescence property, the probe reaction can be used to quantitatively evaluate the function and distribution of UGT1A10 in various biological systems in real time. Moreover, the metabolic product is single (only one monoglucuronidation product is generated), the metabolic enzyme is highly selective (mainly metabolized by UGT1A10), and the metabolic product is easy to detect.

[0007] To achieve the above technical purpose, the technical scheme adopted by the present application is: A glucuronosyltransferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum positioning function, the substrate is not used for diagnosis and treatment of diseases, the probe substrate can be specifically catalyzed by metabolic enzyme to generate corresponding oxygen glucuronoside product, the substrate has 1, 8-naphthalimide structure, and the structure of the substrate is shown as formula (I): , named N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide.

[0008] A preparation method of a glucuronosyltransferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum positioning function, characterized by comprising the following preparation steps: taking 1eq N, N-dimethyl-ethyl-4-bromo-1, 8-naphthalimide and 1-1.5eq p-hydroxyphenylboronic acid as raw materials, 0.02-0.05eq palladium acetate and 1-2eq potassium carbonate as catalysts to start the reaction, water and isopropyl alcohol as solvents, nitrogen protection, reaction temperature 50 DEG C, stirring, reaction time 8h, column chromatography purification, and the obtained light yellow solid is the target product.

[0009] The application of a glucuronosyltransferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum positioning function, using the specific substrate, carrying out glucuronidation binding reaction in a buffer system containing uridine diphosphate glucuronic acid (UDPGA), and determining the activity of UGT1A10 in different biological systems by quantitatively detecting the elimination amount of the substrate or the generation amount of the glucuronidation product per unit time.

[0010] Further, during detection, the substrate concentration is 1 / 2-10 Km, the reaction temperature is 20-60 DEG C; the incubation system pH is 5.5-10.5, and the reaction is terminated when the generation amount of the above substrate corresponding glucuronidation product reaches the quantitative limit and the substrate conversion rate is not more than 20%.

[0011] Further, during detection, the substrate concentration is 1 / 2-10 Km, the reaction temperature is 20-60 DEG C; the incubation system pH is 5.5-10.5, and the reaction is terminated when the generation amount of the above substrate corresponding glucuronidation product reaches the quantitative limit and the substrate conversion rate is not more than 20%.

[0012] Further, the probe substrate does not have fluorescence properties, but the glucuronidation product generated by the metabolic enzyme has good fluorescence properties, and belongs to the "OFF-ON" type fluorescent probe, and the fluorescence spectrophotometer or liquid phase-fluorescence detector is used to realize rapid and sensitive detection of the product; the fluorescence detection conditions of the glucuronidation substrate are: excitation wavelength 365 nm, and maximum emission wavelength 445 nm.

[0013] The specific fluorescent probe glucuronidation product has green fluorescence, which is not easily interfered by the matrix and impurities in the UGT1A10 activity detection process, and can be used for real-time quantitative determination of the UGT1A10 enzyme activity of various human and animal recombinant UGT1A10 single enzymes and various tissue cells; the fluorescence detection method of the probe glucuronidation metabolic product can also be used for rapid screening of UGT1A10 inhibitors and precise evaluation of the inhibition capacity.

[0014] As the fluorescent probe substrate of the high-specificity UGT1A10 single enzyme, the compound can be used to detect the activity of UTG1A10, and is especially suitable for determination of the enzyme activity of the UTG1A10 expressed by the mammalian cell system, and calibration of the activity of UGT1A10 in the microsomes and other preparations.

[0015] The metabolic product of N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide in the application has the characteristics of fluorescence properties (emission wavelength 380-600 nm), single metabolic product (only one glucuronidation product is generated), high specificity (mainly metabolized by UGT1A10), and easy detection and high sensitivity of the substrate and the metabolic product. In addition, the probe has the characteristics of low toxicity, and therefore it is safer as an in vivo UGT1A10 probe.

[0016] The UGT1A10 specific probe described in the application has the following outstanding advantages when used to detect the UGT1A10 enzyme activity: (1) High specificity: N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide can be highly specifically metabolized by UGT1A10 enzyme into one metabolic product, i.e. the glucuronide product.

[0017] (2) Inexpensive and easy to obtain: the probe molecule can be prepared by simple chemical synthesis method, the synthesis process is simple, the cost is low; combined with fluorescence detection method, the overall detection cost is low, easy to popularize and apply.

[0018] (3) High sensitivity: the glucuronidation metabolite based on the 1, 8-naphthalimide parent nucleus structure has excellent fluorescence emission characteristics (emission wavelength 380-600 nm), high fluorescence quantum yield, and can realize high sensitivity detection of enzyme activity. Through the establishment of the standard curve of the metabolite for quantification, the minimum detection limit of UGT1A10 single enzyme can reach 5 μg. BRIEF DESCRIPTION OF DRAWINGS

[0019] Figure 1 The structural formula of N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide of the application is as follows: Figure 2 The structural formula of N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide of the application is as follows: 13 C-NMR spectrum; Figure 3 The structural formula of N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide of the application is as follows: 1 H-NMR spectrum; Figure 4 The fluorescence emission spectrum (Em = 445 nm) of the glucuronidation metabolite of N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide of the application is as follows: Figure 5 The N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide human UGT recombinant enzyme screening result graph of the application is as follows: Figure 6 The N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide glucuronidation metabolic pathway graph of the application is as follows: Figure 7 The linear fitting graph of the generation amount of glucuronidation metabolite with incubation time is as follows: Figure 8 The linear fitting graph of the generation amount of glucuronidation metabolite with incubation protein is as follows: Figure 9 The synthesis route graph of N, N-dimethyl-ethyl-4'-hydroxy-1, 8-naphthalimide of the application is as follows: Figure 10This image shows the co-localization fluorescence of N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthylimide in MCF-7 cells, as described in the present invention. (a) Bright field; (b) Green channel (fluorescence signal of N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthylimide); (c) Red channel (fluorescence signal of ER-Tracker Red); (d) Overlay of N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthylimide and ER-Tracker Red channels; (e) Bright field; Overlay of N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthylimide and ER-Tracker Red channels; (f) Fluorescence intensity in the white-lined region of image d. Figure 11 The images show colocalization fluorescence of the probe UPr6 in MCF-7 cells; (a) bright field; (b) green channel (fluorescence signal of UPr6); (c) red channel (fluorescence signal of ER-Tracker Red); (d) overlay of UPr6 and ER-Tracker Red channels; (e) bright field; overlay of UPr6 and ER-Tracker Red channels; (f) fluorescence intensity of the white line region in Figure d. Figure 12 This invention relates to the MTT assay analysis of the cytotoxicity of N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide. Detailed Implementation

[0020] The technical solution of the present invention will be further described below with reference to specific embodiments, but it is not limited thereto.

[0021] Example 1 The synthetic route for the probe substrate N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide of this invention: Under nitrogen protection, the following were added to a 25 mL two-necked flask: 1 mmol of N,N-dimethyl-ethyl-4'-bromo-1,8-naphthalimide, 1.5 mmol of p-hydroxyphenylboronic acid, 10 mg of palladium acetate, and 276 mg of potassium carbonate. The mixture was heated in an oil bath to 50 °C and stirred overnight. After the reaction was complete, the mixture was cooled to room temperature, and 20 mL of ethyl acetate was added. The mixture was extracted three times with saturated brine to remove the solvent. The remaining solid was purified by silica gel column chromatography (ethyl acetate:petroleum ether = 1:5, v / v) to give a pale yellow solid. The spectral data of the product N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide are shown below. Figures 2-3 As shown; the compound structure diagram is as follows. Figure 1 The synthetic route of the compound is as follows Figure 9 As shown.

[0022] 13 C NMR (100 MHz, DMSO-d6): δ 163.9, 163.9, 163.7, 158.5, 146.9, 131.6,131.2, 131.0, 129.8, 129.2, 128.2, 127.7, 122.8, 120.9, 116.1, 56.96, 45.8, 38.0.

[0023] Example 2 Emission spectroscopy determination of glucuronide products (1) Prepare a 100 μL UGT metabolic reaction system in advance, including 100 μL Tris-HCl (50 mM, pH 7.4), 0.2 mg / mL human liver microsomes or 0.08 mg / mL UGT1A10 single enzyme, 5.0 mM MgCl2, 2 mM UDPGA and probe substrate (final concentration 20 μM). (2) Add UDPGA (final concentration 2 mM) to the reaction system to start the reaction; (3) After 120 min, add 200 μL of ice-cold methanol, shake vigorously, and then terminate the reaction; (4) After centrifuging at 4℃ and 15,000 rpm for 20 min using a high-speed refrigerated centrifuge, the supernatant was collected and subjected to a full-wavelength fluorescence spectral scan (Ex = 365 nm, Em = 380-600 nm); the maximum emission wavelength of N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide glucuronide was 445 nm. Figure 4 ).

[0024] Example 3 In vitro determination of the selectivity of recombinant human UGT single enzyme (1) Prepare a 100 μl UGT metabolic reaction system in advance, including Tris-HCl buffer (50 mM, pH 7.4), each recombinant human UGT single enzyme (0.08 mg / mL), and the final concentration of the probe is 20 μM. Shake and incubate at 37℃. (2) Add UDPGA (final concentration 2 mM) to the reaction system to start the reaction; (3) After 120 minutes, add 100 μL of ice-cold methanol, shake vigorously, and then terminate the reaction; (4) After centrifuging at 4℃ and 15,000 rpm for 20 min using a refrigerated centrifuge, the supernatant was collected for fluorescence detection (Ex = 365 nm, Em = 445 nm); the selectivity of recombinant human UGT1A10 enzyme is about 20 times that of other single enzymes.Figure 5 A schematic diagram of the metabolic pathway of N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide being glucuronidated by UGT1A10 is shown below. Figure 6 As shown.

[0025] Example 4 UGT1A10 Time Standard Curve Determination N,N-Dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide 20 μM, UDPGA (2 mM), MgCl2 (5 mM), UGT1A10 (0.08 mg / mL), Tris-HCl (pH 7.4, 50 mM) buffer, total volume 100 μL, incubated at 37℃ for 10–190 min. A standard curve was plotted based on the fluorescence intensity and incubation time of the product. The regression coefficient R0 of the standard curve was calculated. 2 >0.99 ( Figure 7 This indicates that the probe can accurately quantify the content of UGT1A10.

[0026] Example 5 UGT1A10 protein concentration standard curve determination N,N-Dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide 5 μM, UDPGA (2 mM), MgCl2 (5 mM), UGT1A10 (0–0.08 mg / mL), Tris-HCl (pH 7.4) buffer 50 mM, total volume 200 μL, incubated at 37°C for 60 min. The fluorescence intensity of the product was linearly regressed against the concentration of UGT1A10 protein in the reaction system, and the regression coefficient R0 was obtained. 2 >0.99 ( Figure 8 This indicates that the probe can accurately quantify the content of UGT1A10.

[0027] Example 6 Cytotoxicity test analysis The cytotoxicity of the probes was assessed using the CCK8 assay (all cell lines were purchased from the Peking Union Medical College Cell Bank). The procedure was as follows: Cells in logarithmic growth phase were inoculated at 5.0 × 10⁻⁶ cells / year. 3Cells were seeded at a concentration of [number] cells / mL in 96-well plates of DMEM medium (containing 10% FBS) and incubated overnight in an incubator (5% CO2, 37°C). Then, cells were treated with different concentrations of the probe described herein (0, 20, 40, 60, and 80 μM). After 24 hours of incubation, the blank medium was replaced with 10 μL of CCK8 solution per well, and the cells were incubated for 2 hours. The cell culture medium in the 96-well plates was then discarded, and 180 μL of DMSO was added to each well. Cell viability was measured at 560 nm using a molecular reader. Cell viability without the probe described herein was considered 100%. Figure 12 The results showed that N,N-dimethyl-ethyl-4'-hydroxy-1,8-naphthalimide had almost no cytotoxicity to human cancer cells MCF-7 (after incubation with 20 μM probe for 24 h, the cells had good morphology and a cell survival rate of over 80%).

[0028] Example 7 Comparison of the endoplasmic reticulum colocalization of the probe of this invention with that of the traditional probe UPR6 in MCF-7 cells: The structural formula of UPr6 is: Cells were incubated in a cell culture incubator (5% CO2, 37°C). The culture medium was high-glucose DMEM containing 10% FBS and 1% antibody. Cells in the logarithmic growth phase were seeded in 20 mm confocal dishes (5.0 × 10⁻⁶ cells / mL). 3 L -1 Cells were cultured adherently for 24 hours. Before use, the cells were washed three times with blank culture medium, and 20 μM of probe and 5 μM of ER-Tracker Red were added. The cells were incubated in a cell culture incubator for 30 min, and then washed three times with PBS (pH 7.4) to remove residual probe. The cells were then scanned and imaged using a Zeiss confocal fluorescence microscope (LSM880 with Airyscan).

[0029] Experimental results are as follows Figures 10-11 As shown, the probe substrate of the present invention has a better positioning effect than the traditional probe UPr6, with a co-positioning coefficient as high as 0.96.

[0030] It should be noted that the above embodiments are merely some preferred embodiments of the present invention, and not all embodiments. Obviously, based on the above embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort should fall within the scope of protection of the present invention.

Claims

1. A fluorescent probe substrate for a glucuronyl transferase UGT1A10 with endoplasmic reticulum localization function, wherein the substrate is not used for the diagnosis and treatment of diseases, characterized in that, The structural formula of the substrate is shown in formula (I): .

2. A method for preparing a specific fluorescent probe substrate for glucuronyl transferase UGT1A10 with endoplasmic reticulum localization function as described in claim 1, characterized in that, The preparation process includes the following steps: using 1 eq N,N-dimethyl-ethyl-4-bromo-1,8-naphthalimide and 1-1.5 eq p-hydroxyphenylboronic acid as raw materials, 0.02-0.05 eq palladium acetate and 1-2 eq potassium carbonate as catalysts, water and isopropanol as solvents, under nitrogen protection, at a reaction temperature of 50°C, with stirring, for a reaction time of 8 h, and purified by column chromatography to obtain a pale yellow solid, which is the target product.

3. The application of the glucuronyl transferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum localization function as described in claim 1, characterized in that, Using this specific substrate, a glucuronidation binding reaction was carried out in a buffer system in the presence of uridine diphosphate glucuronic acid. The activity of UGT1A10 in different biological systems was determined by quantitatively detecting the amount of substrate eliminated or the amount of glucuronidation products generated per unit time.

4. The application of the glucuronyl transferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum localization function according to claim 3, characterized in that, During detection, the substrate concentration was 1 / 2-10 Km, the reaction temperature was 20-60℃, and the incubation system pH was 5.5-10.

5. The reaction was terminated when the amount of the corresponding glucuronidation product of the above substrate reached the limit of quantitation and the substrate conversion rate did not exceed 20%.

5. The application of the glucuronyl transferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum localization function according to claim 4, characterized in that, During the assay, the substrate concentration was 5-10 Km, the reaction temperature was 37℃, and the pH of the incubation system was 7.

4.

6. The application of the glucuronyl transferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum localization function according to claim 3, characterized in that, The probe substrate does not have fluorescent properties, but the glucuronidation product generated by its metabolic enzyme has good fluorescent properties. The product can be detected rapidly and sensitively using a fluorescence spectrophotometer or a liquid phase-fluorescence detector. The fluorescence detection conditions for the glucuronidation substrate are: excitation wavelength 365 nm and maximum emission wavelength 445 nm.

7. The application of the glucuronyl transferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum localization function according to claim 3, characterized in that, The biological system is a recombinantly expressed human or mammalian UGT1A10 single enzyme, human or mammalian cells containing UGT1A10, or human or mammalian tissues containing UGT1A10.

8. The application of the glucuronyl transferase UGT1A10 specific fluorescent probe substrate with endoplasmic reticulum localization function according to claim 3, characterized in that, It can also be used for rapid screening of inducers and inhibitors of UGT1A10, as well as for quantitative evaluation of their induction or inhibition capabilities.